SEC Filing Details

SEC Filing Details

Document Details

Form
424B2
Filing Date
Jul 6, 2015
Document Date
Jul 6, 2015
Form Description
Form of prospectus filed in connection with primary offering of securities on a delayed basis
Filing Group
Registration Statements
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE